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In this research. I worked with growth hormone receptor 
knockout mice to examine emDryo survival, fetal and placental 
development in homozygous GHR/BP(KO) and normal females. First. 
I mated the KO and normal females with normal males and checked 
for plugs every day. When the females were at various stages of 
pregnancy, I would kill them with COl and dissected them. Upon 
killing these mice at various stages, I found the number and 
conditions of the fetuses. Also, placental weight, fetus weight, 
and crown-rump length of the fetus were compared between the KO 
and normal females. Therefore, I could detect, if there was a 
significant difference between the fetuses of the KO and normal 
females. 
GHR-KO mice came from Ohio University in Athens, Ohio. 
These mice were made by a disrupted GHR/binding protein (GER/BP) 
gene through a homologous gene targeting approach. Essentially. 
these animals are mammalian models for Laron syndrome in humans. 
Furthermore. the KO mice have characteristics that resemble the 
phenotype of people with Laron syndrome. These characteristics 
consist of dwarfism, absence of the GHR and GH binding protein, 
postnatal growth retardation. decreased serum insulin-like growth 
factor I and elevated serum GH concentrations. The KO mouse 
obtained by disrupting the GHR/BP gene through homologous 
recombination. After two chimeric males transferred the 
disrupted allele to their offspring which the genotype GHR/BP'/', 
heterozygotes. Then, the FI generation of GHR/BP'/' mated to 
produce homozygous GHR/BP'" mice(KO). Thus, the generation of 
GHR-KO mice produced with GHR/BP gene knockout, the Laron mouse 
- .. 
(Zhou, 1997). 
The only fertility information given before.the start of my 
experiment was the report of litter size, perinatal mortality, 
and maturation of the KO(homozygous) and normal (heterozygous) 
females. The litters of normal females reported was 6.90 to 
6.57. Yet, the litters of the KO on the average are 2.71. The 
perinatal mortality was higher in the KO than the normal. 
Furthermore, the maturation of the normal females was six weeks, 
but the maturation in the KO femal~s was 10 weeks. The reason 
given for the smaller litter and higher mortality maybe related 
to placentation, "obstetrical problems" due to maternal-fetal 
size mismatch, and insufficient lactation to nourish pups (Zhou, 
1997) . 
In my study, I assumed that the fetuses of the KO females 
would be smaller than the normal females. The data was collected 
over a period of two months. After checking plugs and 
determining which stage of pregnancy, the mice were killed. 
started from day 14 of pregnancy to day 18. Also, the KO females 
usually had to obtain a plug twice before getting pregnant. 
Table 1 shows the number of mice killed per day. The litter 
sizes of the normal females were 7.125 pups, and the KO females 
were 4.833(Table 2). All the fetuses showed to be in good 
condition, but some KO females gave birth to dead litters. For 
instance, the KO females that did not have a plug date carried to 
term. but one out of seven had live pups. From the normal 
females, only one litter out of three died. The corpus luteum 
was looked at in every female. It has cells that produce 
- .. 
I 
proqesterone to maintain preqnancy until the placenta can produce 
enouqh proqesterone to ta~e over for the corpus luteum. ~hen 
dissectinq the mice, I observed the corpus luteum for ruptured 
follicles which accounted for the fetuses, or absorbed fetuses 
and non-implanted embryos. :n the normal females, the 
non-implanted eqqs were found in only two of the females, but in 
the KO females, it was found in four of the mice. Table 2 shows 
the data of the absorbed fetuses of the normal and KO females. 
There was not a siqnificant difference between the females. 
The data of the placental weiqht, fetal weiqht, and fetal 
lenqth was analyzed on ANOVA. The qraphs showed the mean and 
standard of each day compared with normal and KO females. Also, 
the p value had to show a value less than 0.05 to be 
statistically siqnificant. From the placental weiqht, the data 
showed day 16 and day 17 to have a siqnificant difference. 
Furthermore, the placental weiqht of the KO females was larqer 
than the normal females. The suspected reason for the larqer 
placental weiqht is that the KO mice are secrete a lower level of 
qlucose, so the larqer placenta maybe compensatinq for the l~ck 
of glucose. "he fetus weiqht displayed a siqnificant difference 
at day 14 and day 17. ~ith the fetus lenqth the significant 
difference was found on day 17 and day 18. The qraphs and 
statistics are attached at the end of the paper. 
"0 better the results, more animals mated to qet a larqer 
~u~~er of fetuses. A:so, the aormal females and normal males 
need to be tested for their qenotype, to know if they are +/+ or 
+/-. Knowing the ~enotype of the parents, the study would show 
:f fetuses are both XO and normal mice. If the fetuses are both 
KO and normal, the genotype of the fetuses can be found by taking 
samples of the fetus tissue. 
TABLE 1 
Day l{o Xormal Totc:.l ~umber of Fetuset: ~~orl':1al 1(0 
14 4 3 21 18 
15 3 3 27 13 
16 4 3 21 23 
17 3 3 19 17 
18 4 4 28 ' " ";) 
TABLE 2 
Litter size mean(range) Absorbed Fetus mean(range)~ 
KO 4.833(2 to 8) 1.875(1 to 4)only in 8 KOs 
:>!ormal 7.125(4 to 11) 2(1 to 3)only in 8 normals 
:1or::<s Cited 
Zhou, Yihua., et al. "A mammalian model for Laron syndrome 
Another project I was working on included working with the 
ames dwarf mice. In this experiment, I was to find out the 
effects of replacement therapy with progesterone on pregnancy. 
For several weeks, I injected the df/df females with T4' three 
times a week. The concentration of the T1was 20ug/ml, and the 
amount injected was O.05ml. I mated the mice with normal males 
and checked them. daily for plugs. After a second plug was 
obtained in a df/df female, the mouse was treated with 
progesterone daily. When the df/df reached 14 days, the mouse 
was killed and dissected. Nine mice killed and showed no sign of 
pregnancy. ThereforR, the mice did not carry pregnancy with 
injections of progesterone in sesame oil once a day. 
- .
 
Works Cited 
Zhou, Yihua., et al. "A mammalian model for Laron syndrome 
produced by targeted disruption of the mouse growth hormone 
receptor/binding protein gene (the Laron mouse) ." The National 
Academy of Sciences 1997: 13215-13220. 
- -.
 
Placenta Weight 
130-,-----------------......, 
120 
T 
1 
-0-- NormaltlO 
._..<>....- KO 
loo 
90 
80 +---.----.------,,....------r----..---I 
Days
: ." 
Fetus Height 
25-r-----------------------, 
20 
--0--- Nonna! 
......<>........ KG
 
15 
lO+---r-----r----,------,,..-----r---1 
00
-

Days 
: • 
Fetal Weight 
1250,...----------------~--1 
1000 
II,
, 
{ 
.f,
i 
i 
f
! 
i 
i 
i 
!,
V 
, 
../I750
 --0-- Nannal ........<>........ KO
 
T/ 
500 
250 
o+-----r--....,.----,---r---r--~'" 
~ ~ ~ 
Days 
Day 14 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Analysis 01 Variance Table 
Source: DF SSMurn jQuares: ean SjQuare: F-les : 
Between aroups 1 1139.167 1139.167 2.715 
Within aroups 37 15523.181 419.545 IP=.1079 
Tolal 38 16662.348 
Model II estimate 01 between component variance = 37.123 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Group: Coun: Mean: Sd Dev.: SId Error:t . 
Normal 21 92.664 14.259 3.112 
~ 18 103.506 25.96 6.119 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Com arison: 
Normal vs. KO 
Mean Dill.: 
-10.841 
Fisher PLSD: 
13.331 
Scheffe F-test: 
2.715 
Dunnett t: 
1.648 
Day 15 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Analysis of Variance Table 
S SOFSource: urn sauares: Mean Sauare: 
Between aroups 1 1323.446 1323.446 
Within arouos 38 22394.971 589.341 
Total 39 23718.417 
Model " estimate of between component variance = 41.829 
F-tesl: 
2.246 
10 - .1423 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Grouo: Count: Mean: Std. Dev.: I . Error:S d 
3.73Normal 27 99.783 19.383 
IqJ 13 112.064 32.438 8.997 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Com arison: Mean Dill.: Rsher PLSD: Schelle F-lest: Dunnell t: 
Normal vs. KO -12.281 16.59 2.246 1.499 
Day 16 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Analysis of Variance Table 
Source: DF Sum Sauares: Mean Sauare: F-test: 
Between QrouDs 1 2419.467 2419.467 6.274 
Within arOUDS 42 16197.534 385.656 ID - .0162 
Total 43 18617.001 
Model II estimate of between component variance =92.637 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Groue: Count: Mean: Std. Dev.: Std. Error: 
Normal 21 88.785 21.008 4.584 
~ 23 103.631 18.304 3.817 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Com arison: Mean Dill.: Fisher PLSD: Schelle F-test: Dunnett t: 
Normal vs. KO -14.846 11.962' 6.274' 2.505 
, Significant at 95% 
Day 17 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Analysis of Variance Table 
Source: OF: Sum Souares: Mean Souare: F-test: 
Between aroups 1 3176.043 3176.043 5.656 
Within groues 34 19091.338 561.51 IP = .0232 
Total 35 22267.381 
Model II estimate of between component variance = 145.702 
One Factor AN OVA Xl: Group Yl: Placenta Weight 
Graue: Count: Mean: Std. Dev.: Std. Error: 
Normal 19 93.488 18.04 4.139 
fq) 17 112.303 28.759 6.975 
One Factor ANOVA Xl: Group Yl: Placenta Weight 
Com arison: 
Normal vs. KO 
• Significant at 95"10 
Mean Ditf.: 
-18.815 
Fisher PlSD: 
16.077· 
Scheffe F-test: 
5.656· 
Dunnell t: 
2.378 
, . 
Day 18 
One Factor ANOVA X1: Group Y1: Placenta Weight 
Analysis of Variance Table 
Source: OF S Surn sauares: SMean sauare: F-test: 
Between arOUDS 1 1042.662 1042.662 3.82 
Within arOUDs 41 11191.83 272.971 10 = .0575 
Total 42 12234.492 
Model II estimate of between component variance =39.401 
One Factor ANOVA X1: Group Y1: Placenta Weight 
GrouD: Caunt: Mean: Std. Dev.: S d t . Error: 
2.626Normal 28 94.066 13.894 
14:) 15 104.398 20.667 5.336 
One Factor ANOVA X1: Group Y1: Placenta Weight 
Com arison: Mean Oil!.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO -10.332 10.676 3.82 1.954 
Appz. t7(l/,'X5 
Day 14 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Analysis of Variance Table 
OF SSM;Quares: ean S FSource: urn ;Quare: -lest: 
Between QrOUDS 1 2.354 2.354 2.83 
Within QrOUDS 37 30.783 .832 D = .101 
Total 38 33.137 
Model II estimate of between component variance = .079 
One Factor ANOVA Xl: Group Y3: Fetus Height 
GroUD: Count: ean: t . 0 ev.: S d . Error:M S d t 
21 .15611.91 .713Normal 
.2618 11.417 1.101Kl 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Com arison: Mean Dill.: Rsher PLSD: Schelle F-test: Dunnett t: 
Normal vs. KO .493 .594 2.83 1.682 
Day 15 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Analysis of Variance Table 
Source: OF Sum Sauares: Mean Sauare: F-test: 
Between qroups 1 6.410E-6 6.410E-6 2.523E-6 
Within croups 38 96.53 2.54 I p - .9987 
Total 39 96.53 
Model II estimate of between component variance = -.145 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Group: Count: Mean: Std. Dev.: Std. Error: 
.271 
.536 
Normal 27 13.278 1.41 
Kl 13 13.277 1.934 
One Factor ANOVA Xl: Group Y3: Fetus Height 
C::.:o::.:m~p~a::.:r.:.::is:::o~n.:..: ...,M=ea"'n.:....::D:::,iff"'..:..:__Fisher PLSD: Schelfe F-test: Dunnett t: 
I~N.:.,:o~rm--::;al~v~s.;... I..:.·o_0_1 1_1_.0_8_9 1_2_.5_2_3_E_-6 1..:.·o_o_2 _ .:.,:K..:.o 
Day 16 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Analysis of Variance Table 
Source: OF: Sum Squares: Mean Square: F-test: 
Between aroups 1 9.056 9.056 3.456 
Within qroups 42 110.056 2.62 p = .07 
Total 43 119.112 
Model II estimate of between component variance = .293 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Group: Count: Mean: Std. 0 ev.: Std Error: 
Normal 21 16.095 1.114 .243 
KD 23 15.187 1.968 .41 
One Factor ANOVA Xl: Group Y3: Fetus Height 
Com arison: Mean Difl.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO .908 .986 3.456 1.859 
. .' 
Day 17 
. One Factor ANOVA X1: Group Va: Fetus Height 
Analysis 01 Variance Table 
. FSDuree: OF SSMurn :iQuares: ean Ssquare: -test: 
Between croups 1 105.769 105.769 15.551 
Within oroups 34 231.25 6.801 I p =.0004 
Total 35 337.019 
Model II estimate 01 between component variance = 5.515 
One Factor ANOVA X1: Group Va: Fetus Height 
Group: Caunt: Mean: Std. Dev.: Std. Error: 
.52Normal 19 20.316 2.268 
Kl 17 16.882 2.944 .714
 
One Factor ANOVA X1: Group Va: Fetus Height 
Com arison: Mean Dill.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO 3.433 1.769' 15.551' 3.943 
• Signilicant at 95% 
· . 
Day 18 
One Factor ANOVA X1: Group Va: Fetus Height 
Analysis of Variance Table 
ource:S DF Sum Sauares: Mean Sauare: F-test: 
Between Qraups 1 58.061 18.80558.061 
Within croups 41 126.59 3.088 I p = .0001 
Total 42 184.651 
Model II estimate of between component variance = 2.814 
One Factor ANOVA X1: Group Va: Fetus Height 
Group: Count: Mean: Std. Dev.: Std. Error: 
Normal 28 22.071 .2751.458 
15 19.633 .5742.224~ 
One Factor ANOVA X1: Group Va: Fetus Height 
Com arison: Mean Ditt.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO 2.438 1.135 " 18.805" 4.336 
" Significant at 95% 
Day 14 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Analysis of Variance Table 
Source: OF urn ;Quares: F tSSMean S;Quare: - est: 
Between mOUDS 1 17754.494 17754.494 27.71 
Within QrOUDS 37 23707.008 640.73 ID = .0001 
Total 38 41461.501 
Model" estimate of between component variance = 882.853 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Group: Count: Mean: Sd. 0 Std Error:t ev.: 
Normal 21 242.342 25.857 5.642 
10 18 199.542 24.657 5.812 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Com arison: Mean Dill.: Fisher PLSD: Schelle F-test: Dunnell t: 
Normal vs. KO 42.8 16.474' 27.71' 5.264 
, Significant at 95% 
Day 15 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Analysis of Variance Table 
Source: OF Sum S:;Quares: Mean S:;Quare: F-test: 
Between crOUDS 1 5241.182 5241.182 1.391 
Within croups 38 143213.156 3768.767 D = .2456 
Total 39 148454.339 
Madej II estimate of between component variance = 83.898 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Group: Count: Mean: dSt . Dev.: S d t . Error: 
Normal 27 361.065 36.243 6.975 
~ 13 336.625 95.333 26.441 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Com arison: Mean Diff.: Fisher PLSD: ScheUe F-test: Dunnett t: 
Normal vs. KO 24.439 41.954 1.391 1.179 
Day 16 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Analysis of Variance Table 
SSMurn ean S F-test:Source: DF squares: square: 
Between orouos 1 5957.545 5957.545 .5 
Within qrouos 42 500182.87 11909.116 o = .4833 
Total 43 506140.415 
Model II estimate of between component variance = -271.086 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Grouo: Count: Mean: Std. Dev.: Std. Error: 
Normal 21 535.993 52.097 11.368 
KO 23 559.289 142.367 29.685 
One Factor ANOVA X1: Group Y2: Fetus Weight 
Com arison: Mean Diff.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO -23.296 66.471 .5 .707 
, 
Day 17 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Analysis of Variance Table 
Source: OF: Sum Squares: Mean Square: F-test: 
Between qroUDS 1 731903.155 731903.155 18.707 
Within qroups 34 1330245.955 39124.881 D = .0001 
Total 35 2062149.11 
Model II estimate of between component variance = 38606.839 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
ount: M S d t rror:Group: C ean: t . 0 ev.: S d . E 
Normal 19 1014.361 84.799 19.454 
Iq) 17 728.749 273.954 66.444 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Com arison: Mean Ditt.: Fisher PLSD: Scheffe F-test: Dunnett t: 
Normal vs. KO 285.612 134.2' 18.707' 4.325 
, Significant at 95% 
,. Day 18 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Analysis of Variance Table 
Source: OF: Sum Squares: Mean Square: F-test: 
Between qroups 1 94588.305 94588.305 1.779 
Within croups 41 2180481.388 53182.473 Ip = .1897 
Total 42 2275069.693 
Model " estimate of between component variance =2119.584 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
rouo:G Coun: Mean: Sd 0t . ev.: Std Error: 
Normal 
Kl 
28 
15 
1231.953 
1133.545 
84.886 
376.632 
16.. 042 
97.246 
One Factor ANOVA Xl: Group Y2: Fetus Weight 
Com arison: Mean Dill.: Fisher PLSD: Schelle F-test: Dunnett t: 
Normal vs. KO 98.408 149.021 1.779 1.334 
